EPIDEMIOLOGIC FACTORS, RISK FACTORS AND SCREENING ELEMENTS IN THE CERVICAL NEOPLASIA

Similar documents
THE TREATMENT AND EVOLUTION OF CERVICAL CANCER

INFECTION WITH HUMAN PAPILLOMA VIRUS IN CERVICAL NEOPLASIA

STUDY OF BIOLOGICAL MARKERS IN ENDOMETRIOSIS

I have no financial interests in any product I will discuss today.

Objectives. Background. Background. Background. Background 9/26/16. Update on Cervical and HPV Screening Guidelines: To pap or not to pap?

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

I have no financial interests in any product I will discuss today.

2. Studies of Cancer in Humans

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

DETERMINANT VALUE OF THE CYTOGENETIC AND MOLECULAR IMATINIB THERAPEUTIC RESPONSE IN CHRONIC MYELOID LEUKEMIA

IMMUNOHISTOCHEMICAL IDENTIFICATION OF HUMAN PAPILLOMA VIRUS HIGH-RISK TYPE L1 MAJOR CAPSID PROTEINS IN ATYPICAL GLANDULAR CELLS

Altering Cervical Cancer s Trajectory. Mary S. Beattie, MD, MAS Medical Director, Women s Health BioOncology US Medical Affairs

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today.

Cervical Cancer Screening. David Quinlan December 2013

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Shrestha P CORRESPONDENCE

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

The reproductive health knowledge of

Cervical Cancer Screening

Chapter 10: Pap Test Results

Clinical Practice Guidelines June 2013

Estimated New Cancers Cases 2003

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

THE CONSEQUENCES OF THE CONGENITAL INFECTION WITH TOXOPLASMA GONDII ON THE OFFSPRING

HEALTH AWARENESS MONTH

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

What is cervical cancer?

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

MORPHO-PATHOLOGICAL APECTS IN ACCIDENTS CAUSED BY LOCAL ANESTHESIA WITH VASOCONSTRICTORS

2

News. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM

For all women aged Cervical Screening. Frequently Asked Questions. States of Guernsey Public Health Services

CURRENT HORMONAL CONTRACEPTION - LIMITATIONS

Knowledge of Carcinoma Cervix among rural women of Reproductive age in Trichy district, India

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

Northern Ireland cervical screening programme. Information for primary care and smear takers

Name : Date of Birth : Social Security #: Age: Address: City: State: Zip Code: Home Phone: Work Phone: Cell Phone: Address: May we leave a

CERVICAL CANCER FACTSHEET. What is cervical cancer?

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

Cervical Precancer: Evaluation and Management

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018

Human Papillomavirus

Prevention, Diagnosis and Treatment of Gynecologic Cancers

TARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.

Cancer Awareness Talk ICPAK 2014

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.

Update on Cervical Cancer Screening. Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014

Update on Cervical Cancer Screening

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

Opinion: Cervical cancer a vaccine preventable disease

HPV AND CERVICAL CANCER

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

International Journal of Biological & Medical Research

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

Eradicating Mortality from Cervical Cancer

Knowledge, Attitudes and Practices Regarding Cervical Cancer and Screening among Haitian Health Care Workers. KAP Survey

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Comparison between Pap smear and visual inspection with acetic acid in screening of premalignant cervical intraepithelial lesion and

PATTERN AND FACTORS AFFECTING PAP SMEAR TEST IN NABLUS, A RETROSPECTIVE STUDY

How do we compare? IP724/BMTRY Introduction to Global and Public Health. Feb 21, 2012 Basic Science Rm Sharon Bond, PhD, CNM

ON THE ACTIVITY OF AMYLASES DACTYLIS GLOMERATA

Cervical Cancer Prevention Month. January 2011 Morehouse College

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Pap Smear and Histopathological Study of Cervical Lesions

Teenage Women s Use of Contraceptives in Two Populations

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE

HPV the silent killer, Prevention and diagnosis

PAP smear. (Papanicolaou Test)

14. Cancer of the Cervix Uteri

He Said, She Said: HPV and the FDA. Audrey P Garrett, MD, MPH June 6, 2014

TISSUE TUMOR MARKER EXPRESSION IN

Screening for Cervical Cancer. Grand Rounds 1/16/13 Meggan Linck

Patient Health Forms

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION

THE DECLINE IN CERVICAL CANCER incidence

Personal Data. Present Symptoms

Study of awareness about early detection of cervical cancer by pap smear screening amongst women of Bhavnagar District

Cervical Cancer : Pap smear

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64

India Factsheet: A Health Profile of Adolescents and Young Adults

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

RESEARCH. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

BCCCP Approved ICD-9 Code List Fiscal Year 2010

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Adolescent HPV Prevalence Survey

Profile Of Cervical Smears Cytology In Western Region Of Saudi Arabia

Vasile Goldiş Western University of Arad, Faculty of Medicine, Obstetrics- Gynecology Department, Romania b

Transcription:

Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, TOM XI, 2010 EPIDEMIOLOGIC FACTORS, RISK FACTORS AND SCREENING ELEMENTS IN THE CERVICAL NEOPLASIA MARIANA BRATU 1, FLORENTINA PRICOP 2, OVIDIU TOMA 3, DRAGOS CRAUCIUC 2, EDUARD CRAUCIUC 2* Keywords: cancer, screening, sexuality, contraception Abstract. Aim. The present study channels and materializes all the efforts made with the purpose of emphasizing a series of correlations between the statistical data and the elements of epidemiology, in order to obtain a profile of the patient with cervical neoplasia, underlining the risk factors that are frequently met in this condition. Material and methods. Between 2001-2009 there were 3472 consults for cervical neoplasia suspicion in the Section of Obstetrics and Gynecology of Sf. Apostol Andrei Emergency Hospital in Galaţi. We specifically investigated 1248 of them (35,9%), and 415 cases presented a changed PAP smear (12,0%). Most cases considered for the study had cytologic smears collected and, where there was an indication, we performed biopsies of the cervix. The cytologic smears were coloured using the Giemsa technique or the method with hematoxylin-eosin (H-E). Results. Based on the cases studied we noticed: an increasing tendency of this class of diseases; sexuality under 20 in 76,9% of the cases; 2 or more partners in 42,4% of the cases, 8/12 pregnancies occured in youth (16-20 years old). Conclusion. The continuously ascending mortality of the cervical cancer in our country justifies completely the fact that all the efforts target the primary and secondary prophilaxis of the disease and emphasizes the necessity to act immediately towards the population by implementing a screening programme that is able to reduce the impact of this neoplasia. INTRODUCTION At the beginning of the twenty-first century cancer still continues to be one of the most serious diseases humankind has had to deal with. The incidence of cancer has increased a lot lately and it is now situated, together with the cardiovasculary diseases and accidents, among the top three places of mortality in all the countries in the world, with no exceptions. The research that has been done lately brought elements that clarified some aspects of the cancer pathogeny and revealed the complexity of the molecular mechanisms that govern cell proliferation and differentiation. The cervical neoplasia is a serious chronic disease, which is very important from the medical and social point of view, with a severe evolution when it is detected in advanced stages, being one of the most complex and difficult problems of the human pathology. The activity of early detecting the cervical carcinoma is not very well organized yet, that is why presently most cases come to the doctor in relatively advanced stages, which need complex interventions that usually have unsatisfactory results. The very rich casuistry that I met in practice ever since I started working in the Obstetrics and Gynecology Section of the Emergency Hospital Sf. Apostol Andrei in Galaţi, made me approach this theme that is of interest for an important segment of the world s population in general and of Romania s population in special, with deep economical and social implications that are caused by the important funds that are necessary for treating each case in particular. The mortality of the cervical cancer in our country is continuously increasing and this totally justifies the fact that we direct all our efforts towards the primary and secondary prophylaxis of the disease and emphasizes the need of an urgent intervention in the population, by implementing a screening programme that will be able to reduce the impact of this neoplasia. Any person who is interested in the social aspects of the medicine will find a challenge in thinking and applying a research model with the purpose of finding out what is the situation of cervical cancer in the rural or urban area. MATERIAL AND METHODS In the period 2001-2009 there were 3472 consults for cervical neoplasia suspicion in the Obstetrics and Gynecology Section of the Emergency Hospital Sf. Apostol Andrei in Galaţi, but we only investigated specifically 1248 women (35,9%), 415 of which had changed PAP smears (12,0%). The methods of diagnosis in the cervical cancer consisted of: Medical history. Incipient cancer does not show any symptoms; when it appears on the background of a benign cervical lesion it can also be accompanied by common leucorrhea that is somewhat more abundent. The symptoms become obvious only in the more advanced forms: purulent leucorrhea that smells (it accompanies big lesions that are 95

Mariana Bratu et al. Epidemiologic factors, risk factors and screening elements in the cervical neoplasia exofitic and overinfected); the hemorrhage is intermitent at the beginning, of little intensity, but it is persistent and it defies any rules, the hemorrhage at contact is maybe the only symptom that suggests a cervical neoplasia (especially in menopause); abundent hemorrage in big quantities that persists for a long time usually accompanies advanced cervical cancers; pain is a late symptom in cervical cancer and it begins when the cancer invades the parametres and links to the nervous terminations that cross that area (especially the back area of the parametres). Gynecologic examination consists of applying the valves, tact combined with abdomen palpation and rectal tact. This complex examination leads us to the diagnosis in case there are some obvious lesions on the cervix, when an elementary biopsy technique represents a simple formality. Most of the cases we considered for study had cytologic smears collected, and where there was an indication made we made biopsies from the cervix. The cytologic smears were coloured by using the Giemsa technique or by the hematoxylin-eosin (H-E) method. The cytologic smear studies the changes that have a hormone nature or the ones with an atypic neoplasic nature of the cells that are taken off the exocervix or from the cervical chanal. The cytological examination was revolutionary for the process of detection and early diagnosis of the cervical cancer. Figure 1. Cytologic smear (www.histopatologie.blogspot.com/2009) Figure 2. Pap smear (detail) (www.colposcopie.ro/despre.html) When interpreting and diagnosing the cytologic smears we used the Babeş-Papanicolau Nomenclature, and also the TBS system (The Bethesda System). Statistic processing. The data were registered in a form that allows them to be recorded in certain categories; a variable will not be recorded under many forms; data grouping will be done on variable categories. The data were centralized in EXCEL and SPSS data bases and were processed with the statistic functions that are considered appropriate. The derived indicators have the role of highlighting the qualitative aspects of an ensemble and target the relationship between different parts of a group of patients or different characteristics, interdependence connections between variables. We used the following derived indicators: indicators of the average value: the simple arithmetic mean, the median, the module; indicators of dispersion: standard deviation, variation. Tests of significance: the test t-student; the test 2; the relative risk (RR); the correlation coefficient (Pearson). RESULTS AND DISCUSSIONS The monitoring of the cases with cervical neoplasia between 2001 2009 indicates an increasing tendency for this class of illnesses (y = 4,22 + 8,40 x), so we estimate that there will be about 88 new cases for the year 2010 (fig. 3). 96

Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, TOM XI, 2010 No. of cases 150 100 50 0 117 109 51 53 24 31 11 8 11 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Figure 3. The Distribution of cervical neoplasia on years of study The average age of the patients was 38,93 ± 12,61 years old, with variations between 17 and 85 years old, most cases being in the age group 31-40 years old (27,7%). When we compared the distribution of the patients on group ages depending on the marital status, we noticed a significant percentage (21,2%) of unmarried women up to the age of 40 years old (p<0,001). The distribution of cases depending on their studies highlighted a frequency of 64,6% with high school studies and a percentage of 34,5% workers. Considering smoking and alcohol consumption as the main risk factors for any kind of medical condition, their association induces a relative risk that is 13 times higher for the patients with cervical neoplasia (RR=13,10; IC95: 6,99 24,56). The patients in the study lot declared in a percentage of 74% that the moment when they began the sexual life was around 16-20 years old. We noticed that 2,4% of the patients have not started their sexual life, 2,9% of the patients began it under 15 years old and 1% had their sexual life beginning at 26 or older (fig.4). 21-26 y 20% over 26 y 1% year no sexual life 2% less 15 y 3% 16-20 y 74% Figure 4. The distribution of cases depending on the beginning of the sexual life The patients declared that 55,1% had only one partner in their sex life, and 29,2% had 2 partners. A relatively small percentage of the patients in these cases had 3 or more partners (8,3%). We also noticed that the percentage of the cases without partners in their sex life was 2,4%. (fig. 5). 97

Mariana Bratu et al. Epidemiologic factors, risk factors and screening elements in the cervical neoplasia 60 55,1 40 % 20 0 29,2 8 5,3 2,4 no partners 1 2 3 4 Figure 5. The Distribution of cases depending on the number of sexual partners The number of sexual intercourses/ week varied from 1 to 7, with the highest frequence of twice / week (49,9%). We noticed that a percentage of 15,9% of the patients did not have sexual intercourse (fig. 6). 60 50 49,9 40 30 20 10 0 15,9 18,3 10,8 4,1 1 no raport 1 2 3 4 >5 Figure 6. The Distribution of cases depending on the number of sexual intercourses per week We found sexually transmitted infections only in 1,2% of the patients. In conclusion, after the statistical processing of the epidemiologic characteristics, we can sketch the profile of the patient with cervical neoplasia as follows : Table 1. The profile of the patient with cervical neoplasia Epidemiologic characteristic Profile % Age group 40 years old 57,1 Marital status married 74,0 Studies High school 64,6 Occupation/job worker 34,5 Life style smoking 31,6 Beginning of sexual life 16-20 years old 74,0 98

Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, TOM XI, 2010 Number of partners 1-2 84,3 Number of sexual intercourse/ week 2 49,9 Heredo-collateral antecedents: cardiovascular diseases (BCV) were frequently met in the patients with cervical neoplasia (23,4%), with a predictive positive value of 66% for the age group over 40. Personal physiolog antecedents: - the first menstruation appeared most frequently at the age of 14 for 52% of the patients; - the interval of the menstrual cycle is 28 days (49,2%); - irregular menstrual cycles met in 8% of the cases; - pain for 29,2% of the patients; - most declarations obtained from the questionnaire sheet the menstrual cycle was normal quantitatively speaking (55,7%). Based on the cases studied, the total number of pregnancies that was recorded was 623, which represents 1,5 pregnancies per patient. We recorded 12 spontaneous abortions (1,9% of the total number of pregnancies) and 256 abortions on request (41,1% of the total number of pregnancies). Oral contraceptives were the most frequently used (22,9%), within a time span of 6 months to 3 years. We proved themore frequent use of contraceptive methods for the patients under 40 years old (p<0,001), married (p=0,017). The gynecologic antecedents led to 2 subtotal hysterectomies (0,5%) and there were 28% cases of bleeding at contact. Based on the cases studied, the pathologic antecedents have the following distribution depending on their frequency: obesity - 12%; HTA - 9,6%; sugar diabetes - 3,4%; cardiopathy - 3,1; trombo-embolies - 0,7. CONCLUSIONS Cervical neoplasia is a serious chronic disease that is very important from the medical and social point of view, with a severe evolution when it is detected in the advanced stages, being one of the most complex and difficult problems of the feminine pathology. The cases studied showed: sexuality under 20 years old in a percentage of 76,9%; 2 or more partners in a percentage of 42,4%. The present study lot presented 8 pregnancies for the 12 women under 20 years old, but this distribution did not show significant differences from the statistic point of view ( 2= 2,16; GL=1; p=0,141). REFERENCES ACOG Committee Opinion #300. 2004. Cervical cancer screening in adolescents. Obstet Gynecol, 104: 885. Castle PE, Schiffman M et al. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis, 191; 1808-1181. Chen CA, Liu CY, Chou HH, et al. 2006. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study, Int J Gynecol Cancer. 16(5): 1801-1808. Crauciuc E, Solonaru L. 1999. Bleeding at contact symptom-signal in cervical cancer. Perinatology Bulletin (The Republic of Moldavia-Chişinău), 3: 23-25. 99

Mariana Bratu et al. Epidemiologic factors, risk factors and screening elements in the cervical neoplasia Crauciuc E. 1998. Aetiopathogenic factors in chronic cervicitis. The study was performed in Moldova area between 1994 and 1997. The British Journal of Family Planning (Romanian edition.), 3(4): 63-65. Kahn JA, Hillard PJ. 2003. Cervical cytology screening and management of abnormal cytology in adolescent girls. J Pediatr Adolesc Gynecol, 16: 167. Miller MG, Sung HY, Sawaya GF, et al. 2003. Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol, 101: 29. 1 Emergency Hospital Sf. Apostol Andrei Galaţi 2 - University of Medicine and Pharmacy Gr.T.Popa Iasi 3 - Alexandru Ioan Cuza University, Iasi, Romania * crauciuc@yahoo.com 100